Clinical Trials Logo

Endometriosis clinical trials

View clinical trials related to Endometriosis.

Filter by:

NCT ID: NCT01822080 Completed - Endometriosis Clinical Trials

Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients

Start date: March 2013
Phase: Phase 3
Study type: Interventional

This study is aimed to evaluate efficacy and safety of dienogest 2 mg oral tablets in the treatment of endometriosis. There will be 2 study phases: a double-blind, randomized, placebo-controlled, parallel-group phase over 24 weeks, and an open-label extension phase with 2 mg DNG daily p.o. over 28 weeks for all subjects who completed the double-blind phase, irrespective of their treatment assignment in the first study phase.

NCT ID: NCT01808170 Completed - Endometrioma Clinical Trials

Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve

Start date: March 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of laparoscopic ovarian cystectomy versus laparoscopic cyst deroofing on ovarian reserve measured by serum levels of anti mullerian hormone and antral follicle count in patients with endometriomas.

NCT ID: NCT01793584 Completed - Endometriosis Clinical Trials

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

Start date: February 2013
Phase: N/A
Study type: Interventional

The purpose of the proposed pilot study is to investigate the effectiveness, cost, safety, and long-term impact on quality of life of laparoscopic hysterectomy (LH) in relation to abdominal hysterectomy (AH) for the treatment of benign gynecologic disease in women through a randomized surgical trial.

NCT ID: NCT01791413 Completed - Endometriosis Clinical Trials

Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas

Start date: March 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the ovarian reserve changes after preoperative depot medroxyprogesterone acetate (DMPA) in women with ovarian endometrioma undergoing laparoscopic cystectomy.

NCT ID: NCT01788722 Completed - Endometriosis Clinical Trials

Regulatory Post Marketing Surveillance Study in Korea

Start date: July 19, 2013
Phase:
Study type: Observational

The objective of the study is to investigate and collect post marketing data on the safety and efficacy of Visanne at follow-up visit after about 6 months of treatment and - for a subset of patients - at optional long-term follow-up visit after about 1 year of treatment under daily practice treatment conditions in Korean women and to obtain data on drug utilization on treatment for endometriosis.

NCT ID: NCT01779232 Completed - Infertility Clinical Trials

Danazol Treatment in Endometriosis Women Before IVF

Start date: October 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether pre-treatment with danazol for at least 4 months before controlled ovarian hyperstimulation for IVF cycles improves pregnancy rate.

NCT ID: NCT01769781 Completed - Endometriosis Clinical Trials

Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence

Start date: January 2013
Phase: Phase 4
Study type: Interventional

The aromatase inhibitor (anastrazole) plus long acting GnRH agonist leuprolide acetate will be tested for the treatment of women with endometriosis recurrence compared with classical GnRH analog treatment. Pain symptom disappearance and disease free time during follow-up will be the outcomes for establishing which medical treatment is the best in endometriosis recurrence treatment.

NCT ID: NCT01767090 Completed - Endometriosis Clinical Trials

A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain

Start date: December 4, 2012
Phase: Phase 2
Study type: Interventional

The main objective for this study is to assess the efficacy and dose-response relationship of ASP1707 in reduction of endometriosis associated pelvic pain. The secondary objectives are to assess the safety, tolerability, Pharmacokinetics of ASP1707, dose response relationship of ASP1707 in reduction of E2 (Estradiol), 24-week efficacy of ASP1707 in reduction of endometriosis associated pain and 24-week safety and tolerability of ASP1707.

NCT ID: NCT01760954 Completed - Endometriosis Clinical Trials

Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain

Start date: December 28, 2012
Phase: Phase 3
Study type: Interventional

A randomized study evaluating the continued safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in pre-menopausal women.

NCT ID: NCT01738932 Completed - Endometriosis Clinical Trials

Genetic Polymorphisms of Mannan-binding Lectin (MBL)and Serum Levels of MBL in Patients With Endometriosis

Start date: December 2006
Phase: N/A
Study type: Observational

The purpose of the study is to investigate the possible association between low levels of MBL and the development of endometriosis